Journal ArticleDOI
Anti-cancer drugs
Reads0
Chats0
About:
This article is published in Current Pharmaceutical Design.The article was published on 2005-03-31. It has received 882 citations till now. The article focuses on the topics: Introductory Journal Article.read more
Citations
More filters
Studio chimico-fisico e biologico di nuove molecole bioattive in soluzione
Scienze Farmacologiche,Xxi Ciclo +1 more
Book ChapterDOI
Antioxidant, Anticancer Activity, and Other Health Effects of a Nutritional Supplement (Galaxy(r))
TL;DR: This is an open access chapter distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dissertation
Malignant melanoma and other malignancies of the nasal cavity and the paranasal sinuses in Sweden
TL;DR: The incidence of SNMM in Sweden increased significantly from 1960 through 2000 but not as rapidly as that of CMM, and the incidence of sinonasal malignancies decreased except for SNMM and adenoid cystic cancer during the study period.
N-substituted-4-phenyl/benzylphthalazin-1-ones
TL;DR: A series of N-substituted 4-phenylphthalazin-1-ones 14aeg bearing different anilines at the N-2 of phthalazin 1-one scaffold via acetyl-flexible linker was designed and synthesized for the development of as mentioned in this paper.
Synthesis and Cytotoxicity of Azasugar Modified Anthraquinone Derivatives
TL;DR: In this paper, a series of novel azasugar modified anthraquinone derivatives have been designed and synthesized by the ammonolysis of N-alkylamino acid with rhine and microwave assisted Ullmann coupling reaction.
References
More filters
Journal ArticleDOI
The status of platinum anticancer drugs in the clinic and in clinical trials.
TL;DR: The status of platinum anticancer drugs currently approved for use, those undergoing clinical trials and those discontinued during clinical trials are updated, and the results in the context of where the field will develop over the next decade are discussed.
Journal ArticleDOI
Natural products to drugs: natural product derived compounds in clinical trials
Mark S. Butler,Mark S. Butler +1 more
TL;DR: Natural product and natural product-derived compounds that are being evaluated in clinical trials or are in registration (as at 31st December 2007) have been reviewed, as well as natural products for which clinical trials have been halted or discontinued since 2005.
Journal ArticleDOI
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John Ramage,A Ahmed,J Ardill,N.D.S. Bax,David J. Breen,Martyn Caplin,Pippa Corrie,J Davar,Albert Davies,Val Lewington,Tim Meyer,John Newell-Price,Graeme J. Poston,N. Reed,Andrea Rockall,William P. Steward,Rajesh V. Thakker,C. Toubanakis,Juan W. Valle,Caroline S. Verbeke,Ashley B. Grossman +20 more
TL;DR: These guidelines update previous guidance published in 2005 and have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour Society with endorsement from the clinical committees of the British Society of Gastroenterology and others.
Journal ArticleDOI
Cellular distribution and functions of P2 receptor subtypes in different systems.
TL;DR: This review is aimed at providing readers with a comprehensive reference article about the distribution and function of P2 receptors in all the organs, tissues, and cells in the body.
Journal ArticleDOI
Natural products: an evolving role in future drug discovery.
Bhuwan B. Mishra,Vinod K. Tiwari +1 more
TL;DR: The present review describes natural products, semi-synthetic NPs and NP-derived compounds that have undergone clinical evaluation or registration from 2005 to 2010 by disease area i.e. infectious, immunological, cardiovascular, neurological, inflammatory and related diseases and oncology.